Literature DB >> 3292104

Aldosterone-producing adenoma presenting with hypokalemic myopathy. Case report and review.

B A Dickson1, R C Franks.   

Abstract

A 9-year-old boy who complained of fatigue, myalgias, and progressive weakness was found to have a markedly elevated serum creatine phosphokinase (CPK). He developed polyuria with polydipsia and was noted to be hypertensive and severely hypokalemic. Treatment with potassium and spironolactone alleviated his signs and symptoms and normalized the blood pressure and CPK. Initial studies revealed low plasma renin activity that did not increase with change from supine to upright position. Plasma aldosterone was consistently elevated in the supine position, decreased with upright posture, and was not suppressed by administration of dexamethasone. Plasma 18-hydroxycorticosterone also was elevated. Enhanced computerized tomography (CT) revealed a mass in the left adrenal that had not been seen on the initial unenhanced scan. Adrenal vein catheterization confirmed elevated plasma aldosterone on that side. Adrenalectomy was performed, and a well-encapsulated adenoma was found at examination of the surgical specimen. Postoperatively, suppression of plasma renin activity continued for many months without signs of aldosterone deficiency.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3292104     DOI: 10.1177/000992288802700707

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  3 in total

Review 1.  Aldosteronoma in children: a partial review of the literature.

Authors:  T Decsi; G Soltész
Journal:  Eur J Pediatr       Date:  1995-03       Impact factor: 3.183

2.  Aldosterone and testosterone producing adrenal adenoma in childhood.

Authors:  K Schmitt; H Frisch; N Neuhold; G Burda; E Schober
Journal:  J Endocrinol Invest       Date:  1995-01       Impact factor: 4.256

3.  An additional child case of an aldosterone-producing adenoma with an atypical presentation of peripheral paralysis due to hypokalemia.

Authors:  E C Dinleyici; N Dogruel; M F Acikalin; B Tokar; B Oztelcan; H Ilhan
Journal:  J Endocrinol Invest       Date:  2007-11       Impact factor: 4.256

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.